Fortress Biotech, Inc.'s Net Worth

$44.9 Million

Estimate Recalculated Nov 8, 2024 04:33PM EST

Who is Fortress Biotech, Inc.?

Fortress Biotech, Inc. has an estimated net worth of $44.9 Million. This is based on reported shares across multiple companies, which include Checkpoint Therapeutics, Inc., AVENUE THERAPEUTICS, INC., MUSTANG BIO, INC., NATIONAL HOLDINGS CORP, CB Pharma Acquisition Corp., and Journey Medical Corp.

SEC CIK

Fortress Biotech, Inc.'s CIK is 0001429260

Past Insider Trading and Trends

2023 was Fortress Biotech, Inc.'s most active year for acquiring shares with 10 total transactions. Fortress Biotech, Inc.'s most active month to acquire stocks was the month of December. 2022 was Fortress Biotech, Inc.'s most active year for disposing of shares, totalling 3 transactions. Fortress Biotech, Inc.'s most active month to dispose stocks was the month of April. 2023 saw Fortress Biotech, Inc. paying a total of $301,255.20 for 4,276,720 shares, this is the most they've acquired in one year. In 2022 Fortress Biotech, Inc. cashed out on 150,000 shares for a total of $0.00, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

NATIONAL HOLDINGS CORP No price found

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 3
—
0
—
—
0
No matching records found

CB Pharma Acquisition Corp. No price found

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-79.38%
-1.02M
—
—
265K
May 20
Form 4
—
0
—
—
0
Mar 16
Form 4
—
0
—
—
0
Feb 3
Form 4
—
0
—
—
0
Oct 9
Form 4
—
0
—
—
0
Mar 18
Form 4
-7.22%
-100.00K
—
—
1.28M
Jan 5
Form 3
—
0
—
—
0
No matching records found

Checkpoint Therapeutics, Inc. (CKPT) Snapshot price: $2.14

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 3
—
0
—
—
0
Form 4
+10.19%
193.91K
—
—
2.1M
Mar 20
Form 4
+9.07%
158.13K
—
—
1.9M
Dec 29
Form 4
+4.86%
80.91K
—
—
1.74M
Sep 25
Form 4
+5.15%
81.41K
—
—
1.66M
Jun 30
Form 4
+5.20%
78.21K
—
—
1.58M
Mar 31 - Apr 4
Form 4
+32.51%
368.91K
—
—
1.5M
Jan 5
Form 4
+36.43%
721.7K
—
—
2.7M
Mar 17
Form 3
—
0
—
—
0
No matching records found

AVENUE THERAPEUTICS, INC. (ATXI) Snapshot price: $2.84

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+13.19%
413.51K
—
—
3.55M
Apr 16
Form 4
+203.56%
2.1M
—
—
3.13M
Jan 2
Form 4
+68.15%
418.41K
$0.72
$301,255.20
1.03M
Sep 8
Form 4
+9.33%
52.42K
—
—
613.98K
Mar 31
Form 4
+134.63%
322.23K
—
—
561.56K
Dec 31 - Jan 3
Form 3
—
0
—
—
0
No matching records found

MUSTANG BIO, INC. (MBIO) Snapshot price: $0.2761

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+29.84%
575.19K
—
—
2.5M
Jun 27
Form 4
+27.78%
419.09K
—
—
1.93M
Jan 2
Form 4
+14.16%
2.81M
—
—
22.63M
Jan 6
Form 4
+12.59%
1.13M
—
—
10.13M
Sep 30 - Mar 31
Form 3
—
0
—
—
0
No matching records found